Sell Ajanta Pharma, target Rs 1195.0 : Dr CK Narayan
Sell Ajanta Pharma Ltd. at a price target of Rs 1195.0 and a stop loss at Rs 1225 from entry point.
Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of ₹ 10679.97 Cr.) operating in Pharmaceuticals and health care sector.
Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed ₹ 1753.68 Cr to Sales Value (96.21 % of Total Sales), Export Incentives which contributed ₹ 66.83 Cr to Sales Value (3.66 % of Total Sales) and Other Operating Revenue which contributed ₹ 2.20 Cr to Sales Value (0.12 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 30-06-2017, the company has reported a Consolidated sales of ₹ 473.12 Cr., up 3.73 from last quarter Sales of ₹ 456.12 Cr. and up 4.16 from last year same quarter Sales of ₹ 454.21 Cr. Company has reported net profit after tax of ₹ 94.79 Cr. in latest quarter. The company’s top management includes Dr.Anil Kumar, Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar Dalal, Mr.Purushottam B Agrawal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal. Company has Kapoor & Parekh Associates as its auditors. As on 30-06-2017, the company has a total of 88,006,000 shares outstanding.
Download ET Markets APP